Nilotinib related acute myocardial infarction with nonobstructive coronary arteries: a case report and literature review.
Weiwei ChenBeibei DuKun LiuZhixi YuXingtong WangPing YangPublished in: BMC cardiovascular disorders (2022)
Physicians should be vigilant to adverse vascular events when treating patients who have been prescribed nilotinib. It is suggested that in patients with MINOCA who have a history of treatment with nilotinib, CAS-induced MINOCA should be included in the differential diagnosis. Further studies are needed to clarify the mechanism and to find better management.
Keyphrases
- acute myocardial infarction
- chronic myeloid leukemia
- end stage renal disease
- ejection fraction
- coronary artery disease
- newly diagnosed
- primary care
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- left ventricular
- percutaneous coronary intervention
- high glucose
- heart failure
- emergency department
- drug induced
- aortic stenosis
- genome editing
- acute coronary syndrome
- hypertrophic cardiomyopathy
- endothelial cells
- patient reported
- transcatheter aortic valve replacement
- combination therapy
- aortic valve